Bloomage Financial Statements From 2010 to 2024

Stocks . China . 
Stock . Bloomage Biotechnology Corp
688363 Stock   59.16  1.32  2.28%   
Bloomage Biotechnology financial statements provide useful quarterly and yearly information to potential Bloomage Biotechnology Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bloomage Biotechnology financial statements helps investors assess Bloomage Biotechnology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bloomage Biotechnology's valuation are summarized below:
Gross Profit
6.4 B
Profit Margin
0.0768
Market Capitalization
29 B
Enterprise Value Revenue
4.932
Revenue
5.7 B
We have found seventy-five available fundamental signals for Bloomage Biotechnology Corp, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Bloomage Biotechnology Corp prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Bloomage Biotechnology Total Revenue

3.4 Billion

Check Bloomage Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bloomage Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 11.3 M, Other Operating Expenses of 6.3 B or Net Income Applicable To Common Shares of 562.4 M, as well as many indicators such as . Bloomage financial statements analysis is a perfect complement when working with Bloomage Biotechnology Valuation or Volatility modules.
  
This module can also supplement various Bloomage Biotechnology Technical models . Check out the analysis of Bloomage Biotechnology Correlation against competitors.

Bloomage Biotechnology Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Liabilities225.6 M214.8 M85.3 M
Slightly volatile
Net Tangible Assets3.4 B6.6 B2.6 B
Slightly volatile
Retained Earnings1.4 B2.5 B1.1 B
Slightly volatile
Other Assets337.4 M321.3 M152.3 M
Slightly volatile
Common Stock322.3 M552 M228.1 M
Slightly volatile
Property Plant Equipment2.8 B2.7 B1 B
Slightly volatile
Total Assets5.6 B8.5 B3.8 B
Slightly volatile
Other Current Liabilities5.5 M5.8 M84.9 M
Pretty Stable
Total Current Liabilities830.5 M1.2 B611.2 M
Slightly volatile
Total Stockholder Equity4.6 B6.9 B3 B
Slightly volatile
Accounts Payable735.9 M700.8 M205.6 M
Slightly volatile
Cash1.4 B1.2 B975 M
Slightly volatile
Non Current Assets Total5.6 B5.3 B1.9 B
Slightly volatile
Non Currrent Assets Other266.6 M263.6 M240.1 M
Pretty Stable
Net Receivables391.6 M447.4 M320.7 M
Slightly volatile
Non Current Liabilities Total191.1 M265.8 M121.6 M
Slightly volatile
Inventory586.5 M1.1 B384.2 M
Slightly volatile
Other Current Assets38 M40.1 M70 M
Slightly volatile
Total Liabilities1 B1.5 B732.8 M
Slightly volatile
Deferred Long Term Liabilities38.5 M36.6 M12.4 M
Slightly volatile
Short and Long Term Debt138 M153.1 M151.6 M
Slightly volatile
Total Current Assets3 B3.1 B2.1 B
Slightly volatile
Short Term Debt34.2 M36 M123.3 M
Slightly volatile
Intangible Assets353.9 M497 M222.9 M
Slightly volatile
Good Will134.9 M251.3 M100.1 M
Slightly volatile
Common Stock Shares Outstanding459.2 M481.7 M266.9 M
Slightly volatile
Short Term Investments133 M140 M254.8 M
Slightly volatile
Net Invested Capital5.2 B7.1 B3.3 B
Slightly volatile
Net Working Capital2.4 B1.9 B1.6 B
Slightly volatile
Capital Stock519.4 M481.7 M453.1 M
Slightly volatile
Property Plant And Equipment Net2.3 B3.6 B1.2 B
Slightly volatile
Property Plant And Equipment Gross2.7 B4.3 B1.5 B
Slightly volatile
Capital Lease Obligations44.4 M52.7 M49 M
Slightly volatile
Long Term Debt2.2 M2.3 M122.8 M
Slightly volatile

Bloomage Biotechnology Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses6.3 B6 B1.2 B
Slightly volatile
Net Income Applicable To Common Shares562.4 M1.1 B448 M
Slightly volatile
Income Tax Expense106.5 M193.7 M87.5 M
Slightly volatile
Tax Provision117.2 M119 M88.8 M
Slightly volatile
Selling General Administrative1.5 B3 B939.9 M
Slightly volatile
Total Revenue3.4 B6.1 B2.2 B
Slightly volatile
Gross Profit2.6 B4.5 B1.7 B
Slightly volatile
Operating Income730.2 M737.7 M527.1 M
Slightly volatile
Net Income From Continuing Ops613.9 M582.7 M446.4 M
Slightly volatile
EBIT682.8 M1.3 B565.4 M
Slightly volatile
Research Development468.7 M446.3 M137.9 M
Slightly volatile
Cost Of Revenue1.7 B1.6 B557.4 M
Slightly volatile
Total Operating Expenses5.6 B5.3 B1.8 B
Slightly volatile
Income Before Tax731.1 M701.7 M535.2 M
Slightly volatile
Net Income617.8 M592.6 M448.5 M
Slightly volatile
Interest Income20.6 M38.5 M10.4 M
Slightly volatile
EBITDA901.4 M1.6 B652.3 M
Slightly volatile
Reconciled Depreciation134 M264.7 M85.8 M
Slightly volatile

Bloomage Biotechnology Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Operating Activities594.9 M699.6 M417.2 M
Slightly volatile
Change To Operating Activities73.5 M131.4 M60.2 M
Slightly volatile
Depreciation277.9 M264.7 M91.6 M
Slightly volatile
Dividends Paid294.5 M305.5 M167 M
Slightly volatile
Net Income617.8 M592.6 M448.5 M
Slightly volatile
End Period Cash Flow1.2 B813.1 M901.7 M
Slightly volatile
Begin Period Cash Flow1.3 B1.2 B887.9 M
Slightly volatile

Bloomage Fundamental Market Drivers

Forward Price Earnings41.3223

About Bloomage Biotechnology Financial Statements

Bloomage Biotechnology stakeholders use historical fundamental indicators, such as Bloomage Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bloomage Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bloomage Biotechnology's assets and liabilities are reflected in the revenues and expenses on Bloomage Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bloomage Biotechnology Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue6.1 B3.4 B
Cost Of Revenue1.6 B1.7 B

Currently Active Assets on Macroaxis

TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft
HBIHanesbrands
STLDSteel Dynamics

Other Information on Investing in Bloomage Stock

Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY